Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024

First quarter revenues of $2.37 billion, up 1.5% from 2023 First quarter reported diluted earnings per share ("EPS") of$ 1.72, down 3.4% from 2023; and adjusted diluted EPS of $2.04, flat with 2023 Full year 2024 revenues now expected to be between$ 9.40 billion and $9.48 billion; reported diluted EPS now expected to be between$ 7.57 and $7.82; and adjusted diluted EPS expected to be between$ 8.72 and $8.97 SECAUCUS, N.J., April 23, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leadin ...